Rising Star: Davis Polk's Neal Potischman

Law360, Philadelphia (March 14, 2013, 5:35 PM EDT) -- For successfully helming several of Davis Polk & Wardwell LLP's most high-profile assignments recently, including defeating class certification in a group of cases over off-label marketing of a Pfizer Inc. seizure medication, Neal Potischman has earned a spot among Law360's five rising stars in class action law.

Potischman led the David Polk briefing team responsible for crafting the legal argument that convinced a Massachusetts federal judge to deny class certification to plaintiffs seeking damages in multidistrict litigation over off-label promotion of Pfizer's Neurontin, an anti-seizure medication...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.